EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13)

Ann-Kristin Schmälter iD, Myriam Labopin, Jurjen Versluis, Maria Pilar Gallego Hernanz, Matthias Eder, Peter von dem Borne, Gerard Socié, Patrice Chevallier iD, Edouard Forcade, Andreas Neubauer, Frédéric Baron, Ali Bazarbachi iD und 6 weitere

American Journal of Hematology · 2025

DOI: 10.1002/ajh.27496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hematology, 2025. Verfasst von Ann-Kristin Schmälter und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Augsburg University Hospital and Medical Faculty, Comprehensive Cancer Center Augsburg, Augsburg, Germany. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Translocation, Genetic, Chromosomes, Human, Pair 8, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) with translocation t(8;16)(p11;p13) represents a rare entity that has been categorized as a disease‐defining recurring cytogenetic abnormality with adverse risk in the 2022 European LeukemiaNet classification. This rating was mainly based on a retrospective analysis comprising patients from several large clinical trials, which, however, included only 21 patients treated with allogeneic stem cell transplantation (alloSCT). Therefore, the European Society for Blood and Marrow Transplantation performed a registry study on a larger cohort to evaluate the role of alloSCT in t(8;16) AML. Sixty transplant recipients with t(8;16) AML were identified. Two‐year overall and leukemia‐free survival (OS/LFS) was 43/39%. Patients transplanted in first complete remission (CR1, n = 44) achieved a 2‐year OS/LFS of 48%/48%. Following alloSCT in CR1, the multivariable analysis identified a complex karyotype (CK) as a major risk factor for relapse (HR 4.17, p = .016), lower LFS (HR 3.38, p = .01), and lower OS (HR 3.08, p = .017). Two‐year OS/LFS of patients with CK was 19%/19%, in contrast to 67%/67% in patients with t(8;16) outside a CK. Other factors for inferior outcomes were older age and secondary AML. In summary, alloSCT could mitigate the adverse risk of patients with t(8;16) AML not harboring a CK, particularly when performed in CR1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteTranslocation, GeneticChromosomes, Human, Pair 8Hematopoietic Stem Cell TransplantationChromosomes, Human, Pair 16HumansMaleAdultFemaleMiddle AgedAdolescentRetrospective StudiesYoung AdultAgedTransplantation, HomologousDisease-Free SurvivalAllograftsRemission Induction

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Augsburg University Hospital and Medical Faculty, Comprehensive Cancer Center Augsburg, Augsburg, Germany.
  • Bavarian Cancer Research Center (BZKF), Augsburg, Germany.
  • EBMT Paris Study Office, Paris, France.
  • Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands.
  • Hematology Department, CHU de Poitiers, Poitiers, France.
  • Department of Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

ORCID-Profile: Ann-Kristin Schmälter, Patrice Chevallier, Ali Bazarbachi, Gesine Bug, Arnon Nagler

Zitieren

APA

Schmälter, A. K., Labopin, M., Versluis, J., Gallego Hernanz, M. P., Eder, M., von dem Borne, P., Socié, G., Chevallier, P., Forcade, E., Neubauer, A., Baron, F., Bazarbachi, A., Bug, G., Nagler, A., Schmid, C., Esteve, J., Mohty, M., & Ciceri, F. (2025). The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13). American Journal of Hematology. https://doi.org/10.1002/ajh.27496

Vancouver

Schmälter AK, Labopin M, Versluis J, Gallego Hernanz MP, Eder M, von dem Borne P, et al. The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13). American Journal of Hematology. 2025. doi:10.1002/ajh.27496

BibTeX
@article{Schmlter2025,
  author = {Schmälter, Ann-Kristin and Labopin, Myriam and Versluis, Jurjen and Gallego Hernanz, Maria Pilar and Eder, Matthias and von dem Borne, Peter and Socié, Gerard and Chevallier, Patrice and Forcade, Edouard and Neubauer, Andreas and Baron, Frédéric and Bazarbachi, Ali and Bug, Gesine and Nagler, Arnon and Schmid, Christoph and Esteve, Jordi and Mohty, Mohamad and Ciceri, Fabio},
  title = {The role of allogeneic stem cell transplantation in acute myeloid leukemia with translocation t(8;16)(p11;p13)},
  journal = {American Journal of Hematology},
  year = {2025},
  doi = {10.1002/ajh.27496}
}
Kostenlos starten →